Skip to content
home button
Search

A primary goal of the ARLG is to train the next generation of researchers who will help reduce the public health threat of antibacterial resistance.

LEARN MORE
search button
  • Home
  • About
    • Thought Leadership
    • Spotlight on Clinical Trial Sites
    • Spotlight on Mentees
    • ARLG Scientific Agenda
  • Publications
  • News and Events
    • Events
    • Newsletters
  • How to Apply
    • Biorepository Request
    • Protocol Concept
    • Early Stage Investigator (ESI) Grants
    • The Dr. John G. Bartlett ARLG Fellowship
    • Clinical Trial Sites
    • Adjudicator Request
    • Industry Collaborations
    • Request Data
  • SDMC
  • Lab Center
    • About the Laboratory Center
    • ARLG Biorepository
    • FAQs
  • Studies
  • Resources
    • Research Tools and Methods
    • For Patients and the Community
    • Summary of Results

ARLG

Antibacterial Resistance Leadership Group

June 2026

Posted on June 11, 2026June 11, 2026 by AM

The June 2026 newsletter features the new ARLG Innovative Research Tools and Methods page, network news including two ARLG studies featured in a late-breaking session at ESCMID, and a clinical trial site spotlight on the University of Alabama at Birmingham. The newsletter also includes ARLG member spotlights, recent publications, study milestones, and more.

This entry was posted in Newsletter. Bookmark the permalink.

Post navigation

← Innovations in Diagnostic Trials
DOOR Endpoint for ABSSSI Trials Highlighted in Open Forum Infectious Diseases Editorial →
ARLG is supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number UM1AI104681. The content of this website is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Subscribe to the ARLG newsletter to stay connected

Contact Us
 
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.